Pyrrolo(1,4)benzodiazepine Antitumor Antibiotics: Biosynthetic Studies on the Conversion of Tryptophan to the Anthranilic Acid Moieties of Sibiromycin and Tomaymycin

AUTOR(ES)

Hurley, Laurence H.

RESUMO

Biosynthetic intermediates between tryptophan and the anthranilate moieties of tomaymycin and sibiromycin have been suggested, based upon a combination of feeding experiments with either carbon-14-labeled substrates or competition experiments between radiolabeled tryptophan and unlabeled intermediates. In the case of sibiromycin and tomaymycin, substitution of the aromatic ring most likely takes place at the kynurenine stage. Feeding experiments with the anthramycin culture were inconclusive, most likely because of the cell impermeability.

Documentos Relacionados

• A quantitative assay to measure the relative DNA-binding affinity of pyrrolo[2,1-c] [1,4]benzodiazepine (PBD) antitumour antibiotics based on the inhibition of restriction endonuclease BamHI.
• PURITY STUDIES ON POLYPEPTIDE ANTIBIOTICS: BACITRACIN 1
• THE BACTERIAL OXIDATION OF TRYPTOPHAN II. : Defective Metabolism of Anthranilic Acid1
• Esperamicins, a class of potent antitumor antibiotics: mechanism of action.
• Selective Membrane Toxicity of the Polyene Antibiotics: Studies on Natural Membranes